Skip to main content
ACBT logo

ACBT — Investor Relations & Filings

Ticker · 4148 ISIN · KYG0232P1072 TW Manufacturing
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2019-12-06 Regulatory Filings
Country TW Taiwan
Listing TW 4148

About ACBT

www.allcosmos.com

All Cosmos Bio-Tech Holding Corporation specializes in the application of microbiology to develop and manufacture high-performance bio-chemical fertilizers. Its core products utilize a proprietary formulation combining organic matter, beneficial microorganisms, and chemical elements to enhance soil health and productivity. The company also engages in waste reutilization, applying biotechnological processes to convert organic waste into sustainable resources, and conducts research and development of microbial strains for health care and pharmaceutical applications. By leveraging advanced microbial R&D, the organization provides solutions designed to reduce reliance on traditional chemical inputs and promote circular economy principles. Its activities focus on the synthesis of biological and chemical technologies to provide sustainable alternatives for soil management and resource recovery.

Recent filings

Filing Released Lang Actions
108年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (全宇生技-KY) providing information about loan balances and endorsement guarantees for the current and previous months, including limits and cumulative amounts. The content is numerical and related to financial guarantees and loans but does not contain comprehensive financial statements or detailed analysis. The document length is short (630 characters), and it appears to be a regulatory disclosure of financial data rather than a full report or announcement of a report. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about financial guarantees and loan balances without being a full financial report or announcement of a report publication.
2019-12-06 Chinese
108年11月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a brief financial summary table showing monthly and cumulative consolidated net operating revenue figures for a company (全宇生技-KY) in New Taiwan Dollars and functional currency (Malaysian Ringgit) for the period of November 2019 (民國108年11月). The document length is very short (653 characters) and contains only summarized financial data without detailed financial statements or analysis. There is no indication that this is a full annual or interim report, nor is it an announcement of a report publication. The content resembles a brief financial factsheet or summary of key financial figures. Therefore, the most appropriate classification is Fund Information / Factsheet (FS).
2019-12-06 Chinese
公告本公司108年10月份自結合併財務報表中高流動資產、 短期借款、應付短期票及一年內到期之長期負債等財務資訊
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a company (全宇生技-KY) providing specific financial data for October 2019 (108/10 in the ROC calendar). It includes details on current assets, short-term borrowings, short-term notes payable, and long-term liabilities due within one year. The document references a regulatory requirement from the Taiwan Stock Exchange (臺灣證券交易所) and is a brief announcement of financial information rather than a full financial report. The length is short (945 characters), and it primarily serves as a financial update or disclosure rather than a comprehensive report. This fits best with the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-11-28 Chinese
108年11月法人說明會簡報 — 414820191121E001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation by All Cosmos Bio-Tech Holding Corporation, including company profile, operational overview, industry overview, growth and development, and a 2019 Q3 financial report. It contains extensive information about the company's products, business structure, market, and industry context. The presence of slides, charts, and detailed operational and financial data indicates this is a comprehensive investor-focused presentation. It is not a formal annual or quarterly report filing, nor is it a brief earnings release or a regulatory announcement. The document is consistent with an Investor Presentation (IP) as it provides detailed financials, strategy, market position, and operational insights for investors.
2019-11-21 Chinese
108年11月法人說明會簡報 — 414820191121M001.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed presentation from All Cosmos Bio-Tech Holding Corporation, including company overview, operational status, industry background, growth and development, and importantly, financial data for 2019 Q3 and year-to-date 2019 Q1-Q3. It contains consolidated income statements and balance sheets with actual financial figures, indicating substantive financial data. The presence of detailed financial statements for a quarterly period (Q3 2019) and year-to-date data aligns with the definition of an Interim / Quarterly Report (IR). The document is not merely an announcement or a brief summary but includes comprehensive financial data and analysis for a period shorter than a full fiscal year. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2019-11-21 Chinese
108年11月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a scheduled corporate financial briefing (法人說明會) including date, time, location, and links to presentation materials (PDF files). This corresponds to an investor or analyst presentation event rather than a full report or announcement of voting results, management changes, or financial statements. The presence of presentation files and the context of a financial business explanation meeting aligns with the definition of an Investor Presentation (IP). The document length is short and it is not a report publication announcement or certification. Therefore, the classification is Investor Presentation (IP).
2019-11-21 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.